⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001516920

Brusegard David

Reports to the SEC for 1 company · TORONTO, A6

Transactions

12

Companies

1

Filings

6

CIK

0001516920

Forms 4 and 5

Insider transactions

12 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2016-02-16	GENEREX BIOTECHNOLOGY CORPM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+1.67M sh	$0.00	+$1,667.671	5,615,070
2016-02-16	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase OptionM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−1.67M sh	—	—	0
2016-02-09	GENEREX BIOTECHNOLOGY CORPM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+5.58M sh	$0.00	+$5,583.775	3,916,104
2016-02-09	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase OptionM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−546K sh	—	—	0
2016-02-09	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase OptionM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−1.93M sh	—	—	0
2016-02-09	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase OptionM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−595K sh	—	—	0
2016-02-09	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase OptionM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−845K sh	—	—	0
2016-02-09	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase OptionM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+1.67M sh	—	—	1,667,671
2013-10-31	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase Option (right to buy)A Award	Chief Operating Officer	AAward	+845K sh	—	—	845,492
2013-06-06	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase Option (Right to Buy)A Award	Chief Operating Officer	AAward	+595K sh	—	—	595,239
2013-04-01	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase Option (right to buy)A Award	Chief Operating Officer	AAward	+1.93M sh	—	—	1,928,925
2012-06-20	GENEREX BIOTECHNOLOGY CORPCommon Stock Purchase Option (right to buy)A Award	Chief Operating Officer	AAward	+546K sh	—	—	546,448

Recent filings

6

Accepted (ET)
Feb 164
GENEREX BIOTECHNOLOGY CORP0001607062-16-000684
SEC(opens sec.gov)
Feb 124
GENEREX BIOTECHNOLOGY CORP0001607062-16-000655
SEC(opens sec.gov)
Nov 14
GENEREX BIOTECHNOLOGY CORP0001554795-13-000645
SEC(opens sec.gov)
Jun 104
GENEREX BIOTECHNOLOGY CORP0001363585-13-000012
SEC(opens sec.gov)
Apr 14
Brusegard David0001363585-13-000006
SEC(opens sec.gov)
Jun 214
Brusegard David0001363585-12-000006
SEC(opens sec.gov)

Companies

1

GENEREX BIOTECHNOLOGY CORPChief Operating Officer

Address

C/O GENEREX BIOTECHNOLOGY CORPORATION 33 HARBOUR SQUARE, SUITE 202

TORONTO, A6, M5J 2G2